Stock Research for MDCO


Featured Broker: Ally Invest

Get the due diligence for another stock.


MDCO Stock Chart & Research Data

The MDCO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MDCO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


MDCO Due diligence Resources & Stock Charts

The MDCO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MDCO Detailed Price Forecast - CNN Money CNN View MDCO Detailed Summary - Google Finance
Yahoo View MDCO Detailed Summary - Yahoo! Finance Zacks View MDCO Stock Research & Analysis -

Stock Analysis

TradeIdeas View MDCO Trends & Analysis - Trade-Ideas Barrons View MDCO Major Holders - Barrons
NASDAQ View MDCO Call Transcripts - NASDAQ Seeking View MDCO Breaking News & Analysis - Seeking Alpha
Spotlight View MDCO Annual Report - OTC Report View MDCO OTC Short Report -
TradeKing View MDCO Fundamentals - TradeKing Charts View MDCO SEC Filings - Bar Chart
WSJ View Historical Prices for MDCO - The WSJ Morningstar View Performance/Total Return for MDCO - Morningstar
MarketWatch View the Analyst Estimates for MDCO - MarketWatch CNBC View the Earnings History for MDCO - CNBC
StockMarketWatch View the MDCO Earnings - StockMarketWatch MacroAxis View MDCO Buy or Sell Recommendations - MacroAxis
Bullish View the MDCO Bullish Patterns - American Bulls Short Pains View MDCO Short Pain Metrics -

Social Media Mentions

StockTwits View MDCO Stock Mentions - StockTwits PennyStocks View MDCO Stock Mentions - PennyStockTweets
Twitter View MDCO Stock Mentions - Twitter Invest Hub View MDCO Investment Forum News - Investor Hub
Yahoo View MDCO Stock Mentions - Yahoo! Message Board Seeking Alpha View MDCO Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for MDCO - Insider Cow View Insider Transactions for MDCO - Insider Cow
CNBC View MDCO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MDCO - OTC Markets
Yahoo View Insider Transactions for MDCO - Yahoo! Finance NASDAQ View Institutional Holdings for MDCO - NASDAQ

Stock Charts

FinViz View MDCO Stock Insight & Charts - StockCharts View MDCO Investment Charts -
BarChart View MDCO Stock Overview & Charts - BarChart Trading View View MDCO User Generated Charts - Trading View

Latest Financial News for MDCO

Is The Medicines Company (MDCO) A Good Stock To Buy?
Posted on Thursday December 13, 2018

A market correction in the fourth quarter, spurred by a number of global macroeconomic concerns and rising interest rates ended up having a negative impact on the markets and many hedge funds as a result. The stocks of smaller companies were especially hard hit during this time as investors fled to investments seen as being […]

The Medicines Company Prices $150 Million of Convertible Notes
Posted on Thursday December 13, 2018

The Medicines Company (MDCO) (the “Company”) today announced that it has priced its private offering of $150 million in aggregate principal amount of its convertible senior notes due 2024. The notes will be senior unsecured obligations of the Company and will mature on January 15, 2024, unless earlier converted or repurchased in accordance with their terms. The notes will be convertible prior to October 15, 2023 only upon the occurrence of certain circumstances and will be convertible thereafter regardless of these circumstances, in either case, into cash, shares of the Company’s common stock or a combination thereof, at the Company’s option.

Here's Why Shares of The Medicines Company Sank 14.5% Today
Posted on Thursday December 13, 2018

Investors aren't happy about the drugmaker's latest capital raise.

The Medicines Company Announces Intention to Offer $150 Million of Convertible Notes
Posted on Wednesday December 12, 2018

The Medicines Company (MDCO) (the “Company”) today announced that it proposes to offer $150 million aggregate principal amount of convertible senior notes due 2024, subject to market conditions and other factors. The notes will be convertible, upon certain conditions, into cash, shares of the Company’s common stock or a combination thereof, at the Company’s option. The interest rate, conversion rate, offering price and other terms will be determined by negotiations among the Company and J.P. Morgan Securities LLC, the initial purchaser of the notes.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.